Drug Channels

OCTOBER 4, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Click here to see the original post from June 2023.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JULY 28, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JUNE 13, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. This year’s review includes the following 10 companies: Eli Lilly and Company, Genentech, GlaxoSmithKline, Janssen, Merck, Novartis, Novo Nordisk, Sanofi, Takeda, and UCB.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Pharmaceutical Technology

JUNE 7, 2023

Fosun Pharma announced that the new facility will improve access to affordable life-saving drugs across west Africa and facilitate the transfer of medical and manufacturing knowledge to the African continent, supporting the long-term growth of the health sector in the region.

Pharmaceutical Manufacturing 96

Pharmaceutical Manufacturing 96

Drug Channels

JANUARY 13, 2025

Registered attendees include senior executives from pharmaceutical manufacturers, pharmacy benefit managers, health systems, physician practices, pharmacies, wholesalers, and more. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Below, I have reproduced our original press release.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

Drug Channels

JULY 24, 2020

He describes how ConnectiveRx's affordability tools can help pharmaceutical manufacturers and patients. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. To learn more, download ConnectiveRx’s free reference: Five Keys to Building a Successful Copay Strategy in the COVID-19 Era. Read on for Frank’s insights.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

pharmaphorum

DECEMBER 28, 2022

In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. She joined NSF in 2017.

Pharmaceutical Manufacturing 119

Pharmaceutical Manufacturing Documentation Pharmaceutical Companies Pharmaceutical Companies 119

Drug Channels

MARCH 15, 2022

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

pharmaphorum

AUGUST 4, 2022

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. She joined NSF in 2017.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Customer Service Vaccines 98

Drug Channels

JULY 23, 2024

It’s time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. You can find links to each company’s data below. Insulin has been the first to deflate—and the Humira biosimilar market may be next.

Drug Pricing 52

Drug Pricing Pharmaceutical Manufacturing Biosimilars 52

Drug Channels

JULY 16, 2024

PBMs’ negotiating leverage against pharmaceutical manufacturers has been a key factor inflating the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs’ list prices and their sales at net prices after rebates, discounts, and other reductions. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

Drug Channels

AUGUST 11, 2020

Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. You can find links to each company’s data below. Is that too much to ask? d/b/a Drug Channels Institute.

Drug Pricing 52

Drug Pricing Pharmaceutical Manufacturing 52

Drug Channels

DECEMBER 10, 2024

PBMs negotiating leverage against pharmaceutical manufacturers has been a key factor inflating the gross-to-net bubble the ever-growing dollar gap between sales at brand-name drugs list prices and their sales at net prices after rebates, discounts, and other reductions. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

Drug Channels

OCTOBER 5, 2021

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, lawyers, consultants, and more. d/b/a Drug Channels Institute.

Biosimilars 75

Biosimilars Pharmaceutical Manufacturing Hospitals Documentation 75

Drug Channels

OCTOBER 11, 2022

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, lawyers, consultants, and more. d/b/a Drug Channels Institute.

Biosimilars 74

Biosimilars Hospitals Pharmaceutical Manufacturing Documentation 74

Drug Channels

APRIL 13, 2021

Time for Drug Channels ' annual update on pricing at six of the largest pharmaceutical manufacturers—Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, and Sanofi. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. You can find links to each company’s data below. d/b/a Drug Channels Institute.

Drug Pricing 40

Drug Pricing Pharmaceutical Manufacturing 40

Drug Channels

MARCH 14, 2022

Key decision makers from top pharmaceutical manufacturers and life sciences companies are registering daily along with leading pharmacies, pharmacy benefit managers, digital health companies, health systems, payers, managed care organizations and other key industry stakeholders. Copyright © 2006-2022 Pembroke Consulting, Inc.

Specialty Pharmacies 74

Specialty Pharmacies Pharmaceutical Manufacturing Hospitals 74

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Copyright © 2006-2023 Pembroke Consulting, Inc. This event is part of The Drug Channels 2023 Video Webinar Series.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing 97

Drug Channels

JUNE 25, 2021

Time for Drug Channels ' annual update on pricing at six of the largest pharmaceutical manufacturers—Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, and Sanofi. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. More than 2,000 people have already registered. You can find links to each company’s data below.

Drug Pricing 40

Drug Pricing Pharmaceutical Manufacturing 40

pharmaphorum

MARCH 8, 2022

I made the decision to join Novo Nordisk in 2006 as a medical manager because I felt this move would best give me the opportunity to have an international career without geographical boundaries whilst remaining close to science and developing solutions for people who are struggling with chronic conditions. . This is hugely exciting for me.

Hospitals 98

Hospitals Pharmaceutical Manufacturing Communication 98

Drug Channels

OCTOBER 13, 2020

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. d/b/a Drug Channels Institute.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Hospitals Documentation Vaccines 40

Drug Channels

OCTOBER 10, 2023

Licenses for our DCI reports are regularly purchased by nearly every entity involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. d/b/a Drug Channels Institute.

Specialty Pharmacies 40

Specialty Pharmacies Biosimilars Pharmaceutical Manufacturing Documentation 40

GMPSOP

FEBRUARY 25, 2023

Table of Contents Importance of sampling in pharmaceutical industry Pharmaceutical sampling procedures are carried out during and at each major processing step during the manufacturing to ensure the highest quality is attained. What are the types of sampling plans in pharmaceutical industry?

Labelling 52

Labelling Packaging Documentation Pharmaceutical Manufacturing 52

PharmaShots

FEBRUARY 27, 2023

facility for manufacturing biologics in his presentation. —a combination of AI, IoT, and Digital Twins—for pharmaceutical manufacturers. Dr. Samir discussed Agilent's new Agilent University idea as well as how the company is creating analytical solutions to enable the smart manufacture of biologics.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Drug Channels

MARCH 18, 2025

2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. WHATS GOING ON Twice a year, the DCI team researches and writes two comprehensive, fact-based, and nonpartisan reports on drug channel economics. In some small way, we aim to make the world a slightly smarter place. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Hospitals 52

Pharmaceutical Technology

MARCH 30, 2023

The WHO said there have been other fatalities in the same vein: in 1995 in Haiti and again in 2006 in Panama which led to the United States Pharmacopoeia (USP) adopting a Gas Chromatography (GC) method capable of separating and quantifying ethylene glycol and diethylene glycol in Glycerin in a revised monograph from 2009.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication 52